These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
620 related articles for article (PubMed ID: 1717578)
1. Some cloned murine CD4+ T cells recognize H-2Ld class I MHC determinants directly. Other cloned CD4+ T cells recognize H-2Ld class I MHC determinants in the context of class II MHC molecules. McKisic MD; Sant AJ; Fitch FW J Immunol; 1991 Nov; 147(9):2868-74. PubMed ID: 1717578 [TBL] [Abstract][Full Text] [Related]
2. Self-thyroid epithelial cell (TEC)-reactive CD8+ T cell lines/clones derived from autoimmune thyroiditis lesions. They recognize self-thyroid antigens directly on TEC to exhibit T helper cell 1-type lymphokine production and cytotoxicity against TEC. Sugihara S; Fujiwara H; Niimi H; Shearer GM J Immunol; 1995 Aug; 155(3):1619-28. PubMed ID: 7543527 [TBL] [Abstract][Full Text] [Related]
3. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2. Chen PW; Ananthaswamy HN J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126 [TBL] [Abstract][Full Text] [Related]
4. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex. Lustgarten J; Waks T; Eshhar Z Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555 [TBL] [Abstract][Full Text] [Related]
5. Allogeneic recognition of class I molecules: anti-H-2Ld repertoire of H-2b mice includes T cells recognizing mutant class II H-2b (Abm12) molecules. Frangoulis B; Urbero B; Pla M Eur J Immunol; 1993 Aug; 23(8):1884-8. PubMed ID: 8344350 [TBL] [Abstract][Full Text] [Related]
6. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules. Wacholtz MC; Patel SS; Lipsky PE J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression. Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957 [TBL] [Abstract][Full Text] [Related]
8. Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells. Herrmann T; Maryanski JL; Romero P; Fleischer B; MacDonald HR J Immunol; 1990 Feb; 144(4):1181-6. PubMed ID: 1968075 [TBL] [Abstract][Full Text] [Related]
9. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens. Tomita Y; Mayumi H; Eto M; Nomoto K J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930 [TBL] [Abstract][Full Text] [Related]
10. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777 [TBL] [Abstract][Full Text] [Related]
11. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants. Golding H; Mizuochi T; McCarthy SA; Cleveland CA; Singer A J Immunol; 1987 Jan; 138(1):10-7. PubMed ID: 2946773 [TBL] [Abstract][Full Text] [Related]
12. Characterization of streptococcal antigen-specific CD8+, MHC class I-restricted, T cell clones that down-regulate in vitro antibody synthesis. Walker PR; Fellowes R; Hecht EM; Lehner T J Immunol; 1991 Nov; 147(10):3370-80. PubMed ID: 1834737 [TBL] [Abstract][Full Text] [Related]
13. CD4+ class I-restricted T cells specific for HIV gp160 315-329. Moore RL; Fox BS Cell Immunol; 1994 Mar; 154(1):43-53. PubMed ID: 7907008 [TBL] [Abstract][Full Text] [Related]
14. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions. Asnagli H; Schmitt-Verhulst AM; Guimezanes A J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464 [TBL] [Abstract][Full Text] [Related]
15. Evidence implicating L3T4 in class II MHC antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines. Wilde DB; Marrack P; Kappler J; Dialynas DP; Fitch FW J Immunol; 1983 Nov; 131(5):2178-83. PubMed ID: 6195255 [TBL] [Abstract][Full Text] [Related]
16. Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo. Shen X; Hu B; McPhie P; Wu X; Fox A; Germain RN; König R J Immunol; 1996 Jul; 157(1):87-100. PubMed ID: 8683160 [TBL] [Abstract][Full Text] [Related]
17. Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice. Shimizu J; Kanagawa O; Unanue ER J Immunol; 1993 Aug; 151(3):1723-30. PubMed ID: 8101546 [TBL] [Abstract][Full Text] [Related]
18. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens. Browning MJ; Huang AS; Reiss CS J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651 [TBL] [Abstract][Full Text] [Related]
19. The T/B cell interaction involved in induction of the mouse IgG2ab suppression is restricted by major histocompatibility complex class I, but not class II molecules. Majlessi L; Bordenave G Eur J Immunol; 1997 Jun; 27(6):1346-52. PubMed ID: 9209483 [TBL] [Abstract][Full Text] [Related]
20. Development of CD4-CD8+ cytotoxic T cells requires interactions with class I MHC determinants. Maruŝić-Galesić S; Stephany DA; Longo DL; Kruisbeek AM Nature; 1988 May; 333(6169):180-3. PubMed ID: 3259290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]